BioCentury
ARTICLE | Financial News

Stemline again amends IPO

January 10, 2013 1:01 AM UTC

Stemline Therapeutics Inc. (New York, N.Y.) again amended its IPO and now plans to sell 2.3 million shares at $10-$12. An $11 price would raise $25 million and value the company at $65 million. Stemline also added Feltl and Sunrise Securities as underwriters; Aegis Capital is also an underwriter. Stemline has now amended its IPO at least three times since the company filed in April 2012 to raise up to $50 million. In July, Stemline amended its IPO to sell 3.5 million shares at $11-$13; and in October, the company amended its IPO to sell 1.8 million shares at $10-$12. ...